| 36.01 Data as of May 22 |  -1.20 / -3.22%Today’s Change | 17.25 Today|||52-Week Range 58.91 | +34.77% Year-to-Date |
| Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Laggard May 21 / TheStreet.com |
| Previous close | 37.21 |
| Today’s open | 37.35 |
| Day’s range | 35.83 - 37.85 |
| Volume | 1,154,746 |
| Average volume (3 months) | 1,980,462 |
| Market cap | $2.2B |
| Dividend yield | 2.78% |
| Earnings growth (last year) | +159.50% |
| Earnings growth (this year) | +18.55% |
| Earnings growth (next 5 years) | +20.50% |
| Revenue growth (last year) | +133.44% |
| P/E ratio | 11.1 |
| Price/Sales | 3.16 |
| Price/Book | 13.46 |
| Today’s change | Today’s % change | |
|---|---|---|
| OPKOPKO Health Inc | -0.05 | -0.72% |
| MDCOThe Medicines Co | -1.18 | -3.50% |
| MYGNMyriad Genetics Inc | -0.77 | -2.33% |
| ARNAArena Pharmaceutical... | -0.07 | -0.88% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $0.96 |
| Annual revenue (last year) | $509.3M |
| Annual profit (last year) | $197.7M |
| Net profit margin | 38.81% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Don Matthew Bailey, MBA |
Chief Operating Officer Stephen Lahue Cartt, MBA |
Corporate headquarters Anaheim, California |
.
